PM1022

Biotheus Inc. · Phase 1 active Small molecule

At a glance

Generic name	PM1022
Sponsor	Biotheus Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of PM1022 in Patients With Advanced Tumors (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PM1022 CI brief — competitive landscape report
PM1022 updates RSS · CI watch RSS
Biotheus Inc. portfolio CI